Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

New York University (NYU)

Status and phase: Completed; Phase 3

Conditions: Tobacco Use Disorder

Treatments: Drug: nicotine transdermal system

Study type: Interventional

Funder types: Other

Identifiers

NCT00067158

NIDA-CTN-0009-1

Details and patient eligibility

About

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking

Exclusion criteria

• Patient is psychotic
• Use of smokeless tobacco
• Use of other smoking cessasation product
• Pregnancy
• Patient has hyper-tension, heart problems, or skin condition